Andere talen Kane Biotech Inc.

Aandelen

KNE

CA4838092084

Beurs gesloten - Toronto S.E. Andere beurzen 21:44:55 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,125 ^CAD	-3,85%		-7,41%	+56,25%

18/04	Transcript : Kane Biotech Inc. - Special Call
15/04	Dechra Veterinary Products, Inc. heeft de overname van 66,66% belang in STEM Animal Health Inc. van Kane Biotech Inc. (TSXV:KNE) afgerond.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Kane Biotech to Host Investor Webinar	16/04
Kane Biotech Up 12% After Reporting Closing of STEM Animal Health Sale	15/04
Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products	15/04
Dechra Veterinary Products, Inc. completed the acquisition of 66.66% stake in STEM Animal Health Inc. from Kane Biotech Inc..	15/04
Kane Biotech Agrees to Sell its Interest in STEM Animal Health for US$8 Million	11/04
Canadian Investment Regulatory Organization Trade Resumption - KNE	11/04
Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health	11/04
Canadian Investment Regulatory Organization Trading Halt - KNE	11/04
Kane Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
Kane Biotech Brief: Says otal revenue for the three months ended December 31, 2023 was $764,997	26/03
Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results	26/03
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health	20/03
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health	20/03
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow	19/03
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow	19/03
Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award	08/03
Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair	22/02
Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair	22/02
Kane Biotech Inc. Appoints Dr. Robert Huizinga as Director and Executive Chair	22/02
Kane Biotech Inc. Files New Patent on Revyvetm Antimicrobial Wound Gel Spray	31/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Kane Biotech Inc.

Aandelen

KNE

CA4838092084

Andere talen

Filters